NEWS
Our Latest News
ARCHIMED acquires SeqCenter, a fast-growing player in cutting-edge DNA and RNA gene sequencing
SeqCenter is a category leader in Next-Generation Sequencing, which can sequence hundreds of thousands of genes in record-time and at low cost.
Global private equity healthcare specialist ARCHIMED announces the acquisition of Pittsburgh, Pennsylvania-based genetic sequencing provider SeqCenter. SeqCenter’s founding scientists initially worked at the University of Pittsburgh. Frustrated with the pace, cost and difficulty of obtaining sequencing data from existing vendors and academic core laboratories, they developed their own approach to gene sequencing, ultimately leaving academia and founding SeqCenter in 2019.
ARCHIMED’s DHG completes its first non-UK acquisition, buying Sweden’s GATE Rehab Development AB
March
3,
2020
ARCHIMED acquires Direct Healthcare Group (DHG) from NorthEdge
December
12,
2019
ARCHIMED appoints three new operating and strategic partners
November
19,
2019
Flash News – Bomi Group launches its 2019-2020 Welfare Plan
November
19,
2019
Provepharm Life Solutions lauréate du prix Galien MedStartUp 2018
November
19,
2019
368